Insights On Enterprise Solutions

  1. Enabling A Four-Fold Increase In Titer For mAb Manufacturing 5/14/2026

    A platform-based upstream strategy increased monoclonal antibody titers fourfold, improving yield, efficiency, and scalability via optimized clones, process design, and rapid scale-up.

  2. Practical Considerations For Your Process Characterization Study 5/14/2026

    Outsourced process characterization can save time, but only with the right preparation. Clear expectations around materials and data interpretation help reduce rework and strengthen confidence.

  3. Pure, Proven, Precise Solutions 5/13/2026

    Controlling particle contamination is critical to patient safety. Hear how deep materials science expertise from semiconductor manufacturing can help mitigate risk and achieve purity standards.

  4. Optimizing Outcomes In ADC Manufacturing 5/13/2026

    As bioconjugates evolve, optimized conjugation and strong process and analytical strategies are essential for ensuring consistent quality, targeted characteristics, and reliable therapeutic performance.

  5. Viral Vector Manufacturing Simplified: A Sponsor's Guide To Smarter CDMO Partnerships 5/13/2026

    Smarter viral vector manufacturing starts with early alignment, realistic scaling, and collaboration. Strategy and transparency reduce risk, control costs, and keep timelines on patients.

  6. Unlocking Durable Allogeneic Cell Therapy 5/13/2026

    Advances in genome engineering and immune evasion are enabling scalable, durable allogeneic cell therapies, overcoming rejection challenges and expanding potential treatments across diverse diseases.

  7. Eliminating The Black Box In Gene Therapy Manufacturing 5/12/2026

    Integrated real-time visibility transforms outsourced gene therapy manufacturing from fragmented, reactive coordination into proactive execution, enabling faster decisions, stronger alignment, improved accountability, and timeline confidence.

  8. 3 Steps To Guide Your Product To Annex 1 Compliance 5/12/2026

    To align with Annex 1 expectations, sponsors should focus on three key steps: understanding the guidelines, selecting the right partners, and futureproofing their manufacturing strategies.

  9. Avoiding Launch Delays With A Proactive Tech Transfer Strategy 5/12/2026

    Commercial success comes from treating tech transfer as a strategic collaboration. Flexible processes, early supply chain planning, and partnerships protect timelines and drive long‑term performance.

  10. Accelerating ADC Analytical Method Development Through Platform Innovation 5/11/2026

    Leverage a platform-based analytical development strategy to accelerate ADC IND readiness through early CQA identification, reduced development risk, and streamlined progression from development to patients.